Inbeeo produced a value story that is dynamic, flexible, and considers common and differentiated value messages across multiple clinical scenarios
The material allowed the client to understand the product opportunities and discuss strategies that can cover all possible scenarios at global and regional level
The material can also leverage payer engagement and product positioning in a challenging market
Our client, a mid-size biopharmaceutical company partnered with Inbeeo to develop a payer value story that can consider different clinical outcomes and be adapted to payers across targeted geographies.
The asset has a new MoA in the neurology area with high unmet needs but in an over-crowded market with many low-cost therapies. Still pending of Phase II results, internal stakeholders need to understand the assets potential value to payers within both best and worst case scenarios as well as different (broader vs narrower) indications and make plans for the development of market access materials that can reflect the product value across geographies.
HOW WE APPROACHED THE CHALLENGE
Inbeeo suggested a multi-step approach from identifying the potential product value within Unmet Needs and current SoC across scenarios; to include engagements with internal stakeholders (global & regional) for alignment on product vision and regional adaptation.